NCT06528977

Brief Summary

This study will implement a Western Diet (WD) to understand cardiometabolic and immune function in middle-aged adults (50- 64 years old). Vascular health, intestinal permeability, and T-cell function will be examined before, during, and after the WD. The WD is a 10-day diet and will consist of 25% of total energy from added sugars.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
14mo left

Started Jul 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress61%
Jul 2024Jul 2027

First Submitted

Initial submission to the registry

July 8, 2024

Completed
9 days until next milestone

Study Start

First participant enrolled

July 17, 2024

Completed
13 days until next milestone

First Posted

Study publicly available on registry

July 30, 2024

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2026

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2027

Last Updated

July 30, 2024

Status Verified

July 1, 2024

Enrollment Period

2 years

First QC Date

July 8, 2024

Last Update Submit

July 29, 2024

Conditions

Keywords

added sugarswestern dietcardiometabolic healthT-cell functionintestinal permeability

Outcome Measures

Primary Outcomes (8)

  • Change in Mean Arterial Blood Pressure (mmHg)

    Comparison between before, during and after western diet

    Over the course of 1-2 months

  • Change in relative brachial artery flow-mediated dilation (%)

    Comparison between before, during and after western diet

    Over the course of 1-2 months

  • Change in absolute brachial artery flow-mediated dilation (mm)

    Comparison between before, during and after western diet

    Over the course of 1-2 months

  • Change in T-cell mitochondria respiration (oxygen consumption rate)

    Comparison between before, during and after western diet

    Over the course of 1-2 months

  • Change in T-cell flow cytometry (%)

    Comparison between before, during and after western diet

    Over the course of 1-2 months

  • Change in intestinal permeability (lactulose : mannitol test)

    Comparison between before, during and after western diet

    Over the course of 1-2 months

  • Change in triglycerides (mg/dL)

    Comparison between before, during and after western diet

    Over the course of 1-2 months

  • Change in cholesterol (mg/dL)

    Comparison between before, during and after western diet

    Over the course of 1-2 months

Study Arms (1)

Western Diet

EXPERIMENTAL

Consumption of 10 days of a diet high in added sugars (25% of total caloric intake)

Other: Western Diet

Interventions

Consumption of 10 days of a diet high in added sugars (25% of total caloric intake)

Western Diet

Eligibility Criteria

Age50 Years - 64 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • ability to provide informed consent
  • men and postmenopausal women aged 50-64 years
  • systolic blood pressure \< 130 mmHg; diastolic blood pressure \< 90 mmHg
  • body mass index (BMI) \<30 kg/m2 and % body fat \< 25% for men and \< 33% for women
  • fasting triglycerides \< 200 mg/dl (\< 2.3 mmol/L)
  • low density lipoprotein (LDL) cholesterol \<160 mg/dl (4.14 mmol/L)
  • fasting plasma glucose \<126 mg/dl (\<7.0 mmol/L)
  • weight stable in the prior 6 months (≤ 2 kg weight change)
  • blood chemistries indicative of normal liver enzymes and renal function (estimated glomerular filtration rate using the Modification of Diet in Renal Disease (MDRD) prediction equation must be \>60 ml/min/1.73 m\^2)

You may not qualify if:

  • current use of medications or supplements known to lower blood triglycerides or cholesterol (e.g., fibrates, statins, high dose niacin, high dose omega-3 supplement)
  • chronic clinical diseases (e.g., coronary artery/peripheral artery/cerebrovascular diseases, heart failure, diabetes, chronic kidney disease requiring dialysis, neurological or autoimmune conditions affecting cognition (e.g. Alzheimer's disease or other forms of dementia, Parkinson's disease, epilepsy, multiple sclerosis, large vessel infarct)
  • major psychiatric disorder (e.g. schizophrenia, bipolar disorder)
  • current or past (i.e., last 3 months) use of anti-hypertensive or other cardiovascular-acting medications known to influence vascular function and/or arterial stiffness
  • current medication use likely to affect central nervous system (CNS) functions (e.g. long active benzodiazepines)
  • concussion within last 2 years and ≥ 3 lifetime concussions
  • heavy alcohol consumption (≥8 drinks/week for women and ≥15 drinks/week for men)
  • recent major change in health status within the previous 6 months (i.e., surgery, significant infection, or illness)
  • current smoking within the past 3 months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Delaware

Newark, Delaware, 19713, United States

RECRUITING

MeSH Terms

Interventions

Diet, Western

Intervention Hierarchy (Ancestors)

DietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Officials

  • Christopher Martens, Ph.D.

    University of Delaware

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Kevin Decker, Ph.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Model Details: A controlled feeding study prepared by registered dieticians. Participants will be pre-tested, provided a 10-day WD to be tested on day 10, then post-tested.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 8, 2024

First Posted

July 30, 2024

Study Start

July 17, 2024

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

July 1, 2027

Last Updated

July 30, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Locations